SODIUM TETRADECYL SULFATE - Generic Drug Details
What are the generic drug sources for sodium tetradecyl sulfate and what is the scope of patent protection?
Sodium tetradecyl sulfate
is the generic ingredient in two branded drugs marketed by Hikma, Elkins Sinn, and Mylan Institutional, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Three suppliers are listed for this compound.
Summary for SODIUM TETRADECYL SULFATE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Master File Entries: | 4 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 11 |
| Patent Applications: | 3,229 |
| What excipients (inactive ingredients) are in SODIUM TETRADECYL SULFATE? | SODIUM TETRADECYL SULFATE excipients list |
| DailyMed Link: | SODIUM TETRADECYL SULFATE at DailyMed |
Recent Clinical Trials for SODIUM TETRADECYL SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Goldman, Butterwick, Fitzpatrick and Groff | PHASE4 |
| University of California, Los Angeles | NA |
| Goldman, Butterwick, Fitzpatrick and Groff | Phase 2 |
Medical Subject Heading (MeSH) Categories for SODIUM TETRADECYL SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM TETRADECYL SULFATE
US Patents and Regulatory Information for SODIUM TETRADECYL SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elkins Sinn | SOTRADECOL | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 005970-005 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Institutional | SOTRADECOL | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 040541-002 | Nov 12, 2004 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Elkins Sinn | SOTRADECOL | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 005970-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mylan Institutional | SOTRADECOL | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 040541-001 | Nov 12, 2004 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | SODIUM TETRADECYL SULFATE | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 209937-001 | Dec 9, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
